Taysha Gene Therapies Inc (TSHA) Annual Balance Sheets

Annual · GAAP · USD millions
Access TSHA quarterly Balance Sheets →
Examining balance sheet movements between Taysha Gene Therapies Inc and Dec 31 2021 reveals how Dec 31 2025 adjusts its asset composition and liability profile.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent319.77
Cash & Short-term Investments319.00
Other Current Assets0.45
Prepaid Expense And Other Assets Current4.43
Total Current Assets324.65
Equipment/Property/Plant Net6.74
Deferred Costs, Leasing, Net, Noncurrent DE10.00
Other Assets, Noncurrent11.94
Assets Held For Sale Not Part Of Disposal Group Current-
Restricted Cash-
Operating Lease Right Of Use Asset9.44
Total Assets343.32
Liabilities
Accounts Payable, Current AC6.28
Accrued Liabilities And Other Liabilities20.28
Deferred Revenue, Current DE0.00
Total Current Liabilities26.55
Long-term debt50.11
Total Long-term Debt50.11
Other liabilities, Noncurrent1.55
Build To Suit Lease Liability-
Operating Lease Liability Noncurrent18.17
Total Liabilities96.38
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock958.43
Retained Earnings / Accumulated Deficit-711.30
Other Equity-0.19
Common Stockholder's Equity246.94
Total Stockholder's Equity246.94
Liabilities & Stockholder's Equity343.32
4 historic quarters locked

Sign in to unlock the full Taysha Gene Therapies Inc balance sheet history.

About Taysha Gene Therapies Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-115202

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License